David Rubenstein
@davidrubenstein·310K subscribers·1.5K videos
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs
Posted
February 16, 2024
Views
19,527
Likes
163
Comments
7
Engagement
0.87%
February 16, 2024
19,527
163
7
0.87%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:19Now PlayingNovartis CEO Vas Narasimhan talks about acquisitions, AI and the future of weight-loss drugs. He speaks on "The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded Feb. 15 in New York.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
